Adenocarcinoma in Barrett's oesophagus: an overrated risk
- PMID: 2920919
- PMCID: PMC1378223
- DOI: 10.1136/gut.30.1.14
Adenocarcinoma in Barrett's oesophagus: an overrated risk
Abstract
Barrett's oesophagus is a risk factor for the development of oesophageal cancer and for this reason annual endoscopic surveillance has been proposed. In this retrospective study of all patients with Barrett's oesophagus diagnosed in a 12 year period carcinoma had developed in only four patients. The incidence of oesophageal cancer in this series was one in 170 patient years, which means a 30-fold increase compared with the general population. The survival of patients with Barrett's oesophagus was not different, however, from an age and sex matched control population. It is concluded that systematic endoscopic surveillance of patients with Barrett's oesophagus is not indicated.
Similar articles
-
Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.Dis Esophagus. 2000;13(1):28-31. doi: 10.1046/j.1442-2050.2000.00069.x. Dis Esophagus. 2000. PMID: 11005328 Review.
-
A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance.Eur J Gastroenterol Hepatol. 2001 Jun;13(6):639-45. doi: 10.1097/00042737-200106000-00005. Eur J Gastroenterol Hepatol. 2001. PMID: 11434588
-
Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.Gut. 2016 Feb;65(2):196-201. doi: 10.1136/gutjnl-2015-309220. Epub 2015 Jun 25. Gut. 2016. PMID: 26113177
-
Review: Barrett's oesophagus in Taiwan.J Gastroenterol Hepatol. 1997 Jun;12(6):S19-22. doi: 10.1111/j.1440-1746.1997.tb00453.x. J Gastroenterol Hepatol. 1997. PMID: 9195407 Review.
-
A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis.Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1355-8. doi: 10.1097/00042737-199912000-00003. Eur J Gastroenterol Hepatol. 1999. PMID: 10654794
Cited by
-
The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.Br J Cancer. 2011 Jul 12;105(2):200-5. doi: 10.1038/bjc.2011.214. Epub 2011 Jun 14. Br J Cancer. 2011. PMID: 21673678 Free PMC article.
-
Clinical implications of molecular changes in pediatric Barrett's esophagus.Curr Gastroenterol Rep. 2012 Jun;14(3):253-61. doi: 10.1007/s11894-012-0252-x. Curr Gastroenterol Rep. 2012. PMID: 22373715 Review.
-
Volumetric laser endomicroscopy in Barrett's esophagus: ready for primetime.Transl Gastroenterol Hepatol. 2020 Apr 5;5:27. doi: 10.21037/tgh.2019.11.16. eCollection 2020. Transl Gastroenterol Hepatol. 2020. PMID: 32258531 Free PMC article. Review.
-
Trypsin activity and bile acid concentrations in the esophagus after distal gastrectomy.Dig Dis Sci. 2006 Jun;51(6):1159-64. doi: 10.1007/s10620-006-8024-9. Dig Dis Sci. 2006. PMID: 16865586
-
The Prevalence of Barrett Esophagus Diagnosed in the Second Endoscopy: A Retrospective, Observational Study at a Tertiary Center.Medicine (Baltimore). 2016 Apr;95(14):e3313. doi: 10.1097/MD.0000000000003313. Medicine (Baltimore). 2016. PMID: 27057907 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical